Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
Posts
- Category: Articles (continued)
- Raptor Plans to Advance RP103 in a Registration Study in Huntington's Disease Based on Favorable Treatment Effects at 36 Months in CYST-HD Trial
- Raptor Receives Orphan Drug Designation for Cysteamine Bitartrate in Huntington's Disease From the European Commission
- Rare, Orphan And Neglected Neurodegenerative Diseases - New Research Announced
- Reach2HD, a Phase II study in Huntington's disease, launched
- Reaching out to the ‘HD family’ at the World Congress on Huntington’s Disease
- Reading University team working to beat Huntingdon's disease
- Rebooted neurons halt brain degeneration in mice
- Recent Nature blog on Sangamo and Huntington's disease
- REGENX BIOSCIENCES AND VOYAGER THERAPEUTICS ANNOUNCE LICENSE AGREEMENT
- ReNeuron’s CTX cell line shows further potential
- Research and Markets: Huntington's Disease Global Clinical Trials Review, H2, 2012
- Research highlights immune molecule’s complex role in Huntington’s disease
- Research Points to Biomarker That Could Track Huntington's Disease Progression
- Research Results from University College Cork Update Knowledge of Small Interference RNAs (siRNAs)
- Research using brains-in-a-dish forces a radical rethinking of Huntington’s disease
- Research Will Explore New Therapies for Huntington’s Disease
- Research4HD.org founded on May 15, 2012 relaunched October 25, 2012: The first website for direct donations to Huntington’s disease Researchers, Foundations and Clinics.
- Researcher in FAU’s Charles E. Schmidt College of Medicine Receives NIH Grant to Further Investigate and Develop Treatments for Huntington’s Disease
- Researchers develop new compound that slows down progression of Huntington's Disease
- RESEARCHERS DEVELOP NEW METHOD TO MAP CHOLESTEROL METABOLISM IN BRAIN
- Researchers discover system that reduces neurodegeneration in Huntington’s disease
- Researchers examines whether MRI can improve accuracy of Huntington’s diagnosis
- Researchers find chemical 'switches' for neurodegenerative diseases
- Researchers find controlling element of Huntington’s disease
- Researchers from Pasteur Institute Detail Findings in Neurons
- Researchers get a closer look at how the Huntington's gene works
- Researchers Identify New Links Between Genetic Abnormality and Brain Function in Huntington’s Disease
- Researchers Restore Neuron Function to Brains Damaged by Huntington's Disease
- Restoration of the striatal circuitry: from developmental aspects toward clinical applications
- Results of Auspex Pharmaceuticals' Phase 3 Registration Trial of SD-809 to be Presented at AAN Annual Meeting
- Retrotope Announces Publication of Preclinical Research Showing Cognitive Improvements in a Huntington’s Disease Model Using Deuterated Polyunsaturated Fatty Acid (D-PUFA) Drug Candidate
- Rhenovia files patents for new treatment of Huntington’s disease based on its innovative biosimulation platform
- Rhenovia launches drug discovery for Huntington's disease, others
- Ricerca, cura e assistenza nella Malattia di Huntington: ultimi risultati raggiunti
- RNA Interference's Hot Partnership With Stem Cells
- Roche and Isis Pharmaceuticals Form Alliance for Huntington's Disease
- Roche gears up for pivotal Phase 3 Huntington’s disease gene-silencing clinical trial
- Roche ramps up Huntington’s disease clinical trial for early- to mid-stage stage patients, considers ways to expand research
- Roche: less frequent dosing for Phase 3 Huntington’s clinical trial, easing burden on patients
- Rottura della segnalazione cellulare porta alla neurodegenerazione
- Salute: la cisteina potrebbe portare benefici nella malattia di Huntington
- Sangamo BioSciences And Collaborators Highlight Widening Applications Of ZFP Therapeutics® In Presentations At Major Gene Therapy Meeting
- Sangamo BioSciences Announces First Presentation of Data from ZFP Therapeutic® for Huntington's Disease at 2012 Annual Meeting of Society for Neuroscience
- Sangamo BioSciences Announces Presentation Of First Demonstration Of In Vivo Efficacy Of Novel ZFP Therapeutic® For Huntington's Disease
- Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms
- Sangamo Therapeutics Announces Nature Medicine Publication Detailing the Activity of Disease Allele-Selective Zinc Finger Proteins in Preclinical Models of Huntington’s Disease
- Sapienza. Trovata la proteina “salva-cervello”
- Scientist Converts Human Skin Cells Into Functional Brain Cells
- Scientists coax brain to regenerate cells lost in Huntington's disease
- Scientists deploy GM sheep in fight to treat Huntington’s disease
Plugin by dagondesign.com
